Structural Analysis of the SARS-CoV-2 Omicron Variant Proteins

被引:23
|
作者
Yang, Qiangzhen [1 ]
Syed, Ali Alamdar Shah [1 ]
Fahira, Aamir [1 ]
Shi, Yongyong [1 ,2 ,3 ,4 ,5 ,6 ]
机构
[1] Shanghai Jiao Tong Univ, BioX Inst, Key Lab Genet Dev & Neuropsychiat Disorders, Minist Educ, 1954 Huashan Rd, Shanghai 200030, Peoples R China
[2] Qingdao Univ, Qingdao Branch SITU, BioX Inst, Biomed Sci Inst, Qingdao 266003, Peoples R China
[3] Shanghai Jiao Tong Univ, Shanghai Mental Hlth Ctr, Shanghai Key Lab Psychot Disorders, Sch Med, Shanghai 200030, Peoples R China
[4] Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6, Shanghai Key Lab Sleep Disordered Breathing, Shanghai, Peoples R China
[5] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou 450052, Peoples R China
[6] Xinjiang Med Univ, Dept Psychiat, Teaching Hosp 1, Urumqi 830046, Peoples R China
来源
RESEARCH | 2021年 / 2021卷
基金
国家重点研发计划;
关键词
SPIKE;
D O I
10.34133/2021/9769586
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The spread of the latest SARS-CoV-2 variant Omicron is particularly concerning because of the large number of mutations present in its genome and lack of knowledge about how these mutations would affect the current SARS-CoV-2 vaccines and treatments. Here, by performing phylogenetic analysis using the Omicron spike (S) protein sequence, we found that the Omicron S protein presented the longest evolutionary distance in relation to the other SARS-CoV-2 variants. We predicted the structures of S, M, and N proteins of the Omicron variant using AlphaFold2 and investigated how the mutations have affected the S protein and its parts, S1 NTD and RBD, in detail. We found many amino acids on RBD were mutated, which may influence the interactions between the RBD and ACE2, while also showing the S309 antibody could still be capable of neutralizing Omicron RBD. The Omicron S1 NTD structures display significant differences from the original strain, which could lead to reduced recognition by antibodies resulting in potential immune escape and decreased effectiveness of the existing vaccines. However, this study of the Omicron variant was mainly limited to structural predictions, and these findings should be explored and verified by subsequent experiments. This study provided basic data of the Omicron protein structures that lay the groundwork for future studies related to the SARS-CoV-2 Omicron variant.
引用
收藏
页数:4
相关论文
共 50 条
  • [41] Audio Interview: Addressing the Omicron Variant of SARS-CoV-2
    Rubin, Eric J.
    Baden, Lindsey R.
    Karim, Salim S. Abdool
    Morrissey, Stephen
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (04):
  • [42] SARS-CoV-2 omicron variant: the black swan of microbiology
    Zhangkai J. Cheng
    Mingshan Xue
    Youpeng Chen
    Yong Zhang
    Baoqing Sun
    [J]. Archives of Microbiology, 2022, 204
  • [43] Reduced pathogenicity of the SARS-CoV-2 omicron variant in hamsters
    McMahan, Katherine
    Giffin, Victoria
    Tostanoski, Lisa H.
    Chung, Benjamin
    Siamatu, Mazuba
    Suthar, Mehul S.
    Halfmann, Peter
    Kawaoka, Yoshihiro
    Piedra-Mora, Cesar
    Jain, Neharika
    Ducat, Sarah
    Kar, Swagata
    Andersen, Hanne
    Lewis, Mark G.
    Martinot, Amanda J.
    Barouch, Dan H.
    [J]. MED, 2022, 3 (04): : 262 - 268.e4
  • [44] A mini review of reinfection with the SARS-CoV-2 Omicron variant
    Shen, Hongwei
    Chen, Dingqiang
    Li, Chenglin
    Huang, Tingting
    Ma, Wen
    [J]. HEALTH SCIENCE REPORTS, 2024, 7 (04)
  • [45] Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant
    Rigel Suzuki
    Daichi Yamasoba
    Izumi Kimura
    Lei Wang
    Mai Kishimoto
    Jumpei Ito
    Yuhei Morioka
    Naganori Nao
    Hesham Nasser
    Keiya Uriu
    Yusuke Kosugi
    Masumi Tsuda
    Yasuko Orba
    Michihito Sasaki
    Ryo Shimizu
    Ryoko Kawabata
    Kumiko Yoshimatsu
    Hiroyuki Asakura
    Mami Nagashima
    Kenji Sadamasu
    Kazuhisa Yoshimura
    Hirofumi Sawa
    Terumasa Ikeda
    Takashi Irie
    Keita Matsuno
    Shinya Tanaka
    Takasuke Fukuhara
    Kei Sato
    [J]. Nature, 2022, 603 : 700 - 705
  • [46] Why Omicron Variant of SARS-CoV-2 is Less Fatal?
    Liao, Lipeng
    Zhang, Jiaming
    Wang, Yuchuan
    Liu, Qiuyun
    [J]. CHEMBIOCHEM, 2022, 23 (13)
  • [47] Genomic Perspectives on the Emerging SARS-CoV-2 Omicron Variant
    Wentai Ma
    Jing Yang
    Haoyi Fu
    Chao Su
    Caixia Yu
    Qihui Wang
    Ana Tereza Ribeiro de Vasconcelos
    Georgii A.Bazykin
    Yiming Bao
    Mingkun Li
    [J]. Genomics,Proteomics & Bioinformatics, 2022, 20 (01) : 60 - 69
  • [48] Challenges of SARS-CoV-2 Omicron Variant and appropriate countermeasures
    Shao, Wenxia
    Zhang, Weiying
    Fang, Xiang
    Yu, Daojun
    Wang, Xianjun
    [J]. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2022, 55 (03) : 387 - 394
  • [49] Structural diversity of the SARS-CoV-2 Omicron spike
    Gobeil, Sophie M-C
    Henderson, Rory
    Stalls, Victoria
    Janowska, Katarzyna
    Huang, Xiao
    May, Aaron
    Speakman, Micah
    Beaudoin, Esther
    Manne, Kartik
    Li, Dapeng
    Parks, Rob
    Barr, Maggie
    Deyton, Margaret
    Martin, Mitchell
    Mansouri, Katayoun
    Edwards, Robert J.
    Eaton, Amanda
    Montefiori, David C.
    Sempowski, Gregory D.
    Saunders, Kevin O.
    Wiehe, Kevin
    Williams, Wilton
    Korber, Bette
    Haynes, Barton F.
    Acharya, Priyamvada
    [J]. MOLECULAR CELL, 2022, 82 (11) : 2050 - +
  • [50] SARS-CoV-2 During Omicron Variant Predominance Among Infants Born to People With SARS-CoV-2
    Gosdin, Lucas
    Chang, Daniel
    Olsen, Emily O'Malley
    Lewis, Elizabeth L. L.
    Wingate, Heather
    Ojo, Kristen D. D.
    Shephard, Hanna
    Sokale, Ayomide
    Mobley, Evan L. L.
    Delgado-Lopez, Camille
    Hall, Aron J. J.
    Gilboa, Suzanne M. M.
    Tong, Van T. T.
    Woodworth, Kate R. R.
    [J]. PEDIATRICS, 2023, 151 (05)